Replies to post #40 on JOURNAL REGISTER CO(NYSE: JRC) (JRC)

[drluck]

Under the NYSE rules, the Company has ten business days to notify the NYSE of its intent to cure this deficiency and six months to cure it or be subject to suspension and delisting. The Company intends to notify the NYSE within the required ten business day period that it intends to cure the deficiency. Under the NYSE rules, the Company's common stock will continue to be listed on the NYSE during the six month cure period, subject to compliance with the other NYSE continued listing requirements.